Akorn (AKRX) PT Lifted to $60 at Guggenheim
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Needham & Company Downgrades Akorn (AKRX) to Hold
February 27, 2015 6:57 AM ESTNeedham & Company downgraded Akorn (NASDAQ: AKRX) from Buy to Hold.
Analyst Elliot Wilbur commented, "AKRX at last delivered its fully loaded clobetasol quarter as price inflation on this formerly obscure asset has yielded a significant inflection point in base generic EPS; a step-up... More
Akorn (AKRX) Tops Q4 EPS by 5c
February 26, 2015 7:11 AM ESTAkorn (NASDAQ: AKRX) reported Q4 EPS of $0.50, $0.05 better than the analyst estimate of $0.45. Revenue for the quarter came in at $227.8 million versus the consensus estimate of $218.87 million.
Akorn sees FY2015 EPS of $1.88-$1.98, versus the consensus of $1.82. Akorn sees FY2015 revenue of $960-980... More
